New combo drug therapy aims to protect hearts after noncardiac surgery
Disease control
Recruiting now
This study tests whether giving a blood thinner (rivaroxaban) and a cholesterol-lowering drug (atorvastatin) can reduce heart-related risks in adults who had a heart injury after noncardiac surgery. The study includes 50 people aged 45 or older who recently had major surgery and …
Phase: EARLY_PHASE1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 22, 2026 16:00 UTC